Holen Sie sich die Stockscreener-App
13.75
0.29%
0.00
Schlusskurs vom Vortag:
$13.75
Offen:
$13.67
24-Stunden-Volumen:
21,963
Relative Volume:
0.53
Marktkapitalisierung:
$339.00M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.2555
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
+3.92%
1M Leistung:
-14.40%
6M Leistung:
+24.35%
1J Leistung:
+97.28%
1-Tages-Spanne:
$13.50
$14.13
1-Wochen-Bereich:
$13.26
$14.22
52-Wochen-Spanne:
$5.742
$16.90
Benitec Biopharma Inc Stock (BNTC) Company Profile
Firmenname
Benitec Biopharma Inc
Sektor
Branche
Telefon
(510) 780-0819
Adresse
3940 TRUST WAY, HAYWARD, CA
Vergleichen Sie BNTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
13.72 | 339.00M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.09 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
559.01 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.73 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.31 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.84 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-12 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-05 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-02-26 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-31 | Bestätigt | Maxim Group | Buy |
| 2015-09-16 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance
Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
JMP Securities Boosts Benitec Biopharma (NASDAQ:BNTC) Price Target to $20.00 - Defense World
Benitec Biopharma (BNTC) Stock Price Target Increased Amid Promi - GuruFocus
Benitec stock price target raised to $20 at JMP Securities - Investing.com Australia
Benitec stock price target raised to $20 at JMP Securities By Investing.com - Investing.com India
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World
Q3 EPS Forecast for Benitec Biopharma Boosted by Analyst - Defense World
Suvretta capital management buys $211,736 in Benitec Biopharma shares By Investing.com - Investing.com Canada
Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
Top 5 Small-cap Biotech Stocks of 2025 - Nasdaq
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 900,000 Shares of Stock - MarketBeat
Benitec Biopharma completes stock and warrant offerings By Investing.com - Investing.com Australia
Suvretta capital purchases $11.7m in Benitec Biopharma shares By Investing.com - Investing.com India
Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market! - TipRanks
Benitec Biopharma completes stock and warrant offerings - Investing.com India
Suvretta capital purchases $11.7m in Benitec Biopharma shares - Investing.com
Benitec Biopharma inks deal granting stock resale rights - Investing.com India
Benitec Biopharma inks deal granting stock resale rights By Investing.com - Investing.com Canada
Benitec Biopharma prices $30M securities offerings - MSN
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire
Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering - TipRanks
Benitec Biopharma Prices $30 Million Equity Offerings - MarketScreener
(BNTC) Trading Report - news.stocktradersdaily.com
Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World
H.C. Wainwright maintains Buy on Benitec BioPharma stock By Investing.com - Investing.com Australia
H.C. Wainwright maintains Buy on Benitec BioPharma stock - Investing.com
Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Up 17.6% in February - Defense World
Benitec Biopharma stock soars to 52-week high of $16.2 By Investing.com - Investing.com Australia
Benitec Biopharma stock soars to 52-week high of $16.2 - Investing.com
Benitec reports progress in OPMD swallowing function study By Investing.com - Investing.com South Africa
Benitec Biopharma Reports Positive Interim Results For BB-301 Gene Therapy In OPMD Clinical Trial - RTTNews
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD By Investing.com - Investing.com South Africa
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma Announces Positive Interim Results for BB-301 - TipRanks
Benitec reports progress in OPMD swallowing function study - Investing.com India
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - The Manila Times
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with ... - The Bakersfield Californian
Benitec Biopharma Reports Positive Interim Clinical Results - GlobeNewswire
Benitec stock holds $18 target, Market Outperform rating By Investing.com - Investing.com UK
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
0.77%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):